Cigarette smoking is a major risk factor in diabetes and contributes to the development of microvascular and macrovascular complications. Despite this, approximately one third of patients with diabetes smoke. Nicotine is physically and psychologically addictive, with multiplefactors contributing to the initiation and continuation of the habit. Cessation is a process in which the smoker progresses through several stages of change, including precontemplation, contemplation, action, maintenance, and relapse. Knowledge of this process is needed for the diabetes health care team to effectively individualize smoking prevention and cessation strategies. This stepped care approach includes preventive, behavioral, and pharmacologic strategies as a component of routine diabetes education.
Get full access to this article
View all access options for this article.
References
1.
US Office on Smoking and Health.Reducing the health consequences of smoking: 25 years of progress: a report of the Surgeon General. Washington, DC: Govemment Pnnting Office. 1989, DHHS publication no. (PHS)89-8411.
2.
Gordon T., Castelli WP, Hjortland MCHigh density lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med1977;62:707-14.
3.
Haire-Joshu D.Smoking cessation: a priority in diabetes care. Diabetes Spectrum1990;3:81-115.
4.
Fisher EB, Haire-Joshu D., Moggun GD, Rehberg H., Rost K.State of the art: smoking and smoking cessation. Am Rev Respir Dis1990;142:702-20.
5.
Davis RMCurrent trends in cigarette advertising and marketing. N Engl J Med1987.316.725-32.
6.
Cummings KM, Giovino G., Mendocino AJCigarette advertising and racial differences in cigarette brand preferences . Public Health Rep1985;53:455-60.
7.
Haire-Joshu D., Fisher EB Jr. The prevalence and clinical impact of smoking in diabetic subjects . Presented before the Society for Behavioral Medicine ; April 1990; Chicago, III.
8.
Jones RB, Hedley AJPrevalence of smoking on a diabetic population: the need for action. Diabetic Med1987;4:233-36.
9.
Chnstlieb ARDiabetes and hypertensive vascular disease. Am J Cardiol1973;32:592-606.
10.
Rytter L., Troelsen S.Beck-Nielsen H.Prevalence and mortality of acute myocardial infarction on patients with diabetes . Diabetes Care1985;8: 230-34.
11.
Gottlieb AM , Killen JD, Marlatt GA, Taylor CBPsychological and pharmacological influences in cigarette smoking withdrawal: effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. J Consult Clin Psychol1987;55:606-8.
Beach KW, Bedford GR, Bergelin RO, et al. Progression in lower extremities arterial occlusive disease in type II diabetes mellitus. Diabetes Care1988,11.464-72.
14.
Lithner F.Is tobacco of importance for the development and progression of diabetic vascular complications? Acta Medica Scand [Suppl]1983;687:33-36.
15.
Muhlhauser I., Sarwicki P., Berger M.Cigarette-smoking as a nsk factor for macroproteinuna and proliferative retinopathy in type I (insulin-dependent) diabetes. Diabetelogia1986;29:500-2.
16.
Eadington DW , Patrick AW, Collier A., Frier BMLimited joint mobility, Dupuytren's contracture, and retinopathy in Type I diabetes: association with smoking. Diabetic Med.6:152-57.
17.
Haire-Joshu D.Heady S.Thomas L., Fisher EB Jc The impact ofsmoking on diabetes care: beliefs of diabetic smokers. Presented before the Amencan Diabetes Association; June 1990; Atlanta, Ga.
18.
Mitchell B. , Hawthome B., Vimk A.Cigarette smoking and neuropathy in diabetic patients. Diabetes Care1990;4:434-37.
19.
Jarvik M., Henningfield JEPharmacological treatment of tobacco dependence. Pharmacol Biochem Behav1988;30:279-94.
20.
Pomerleau OF , Pomerleau CSA biobehavioral view of substance abuse and addiction. J Drug Issues1987; 17:111-31.
21.
Pomerleau OF , Pomerleau CSNeuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev1984,8:503-13.
22.
Henningfield JE, Nemeth-Coslett R.Nicotine dependence — interface between tobacco and tobacco-related disease. Chest1988;93(2):37S-55S.
23.
Shiffman S. , Jarvik MESmoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology1976,50:35-39.
Mermelstein R., Cohen S., Lichtenstein E., Baer JS, Kamarck T.Social support and smoking cessation and maintenance . J Consult Clin Psychol1986;54:447-53.
26.
Hall SM, Tunstall C., Rugg D., Jones RT, Benowitz N.Nicotine gum and behavioral treatment in smoking cessation. J Consult Clin Psychol1985;53:256-58.
27.
West RJ, Hajek P., Belcher M.Time course of cigarette withdrawal symptoms dunng four weeks of treatment with nicotine chewing gum. Addict Behav1987 ;12:199-203.
28.
Kathol EG, Petty F.Relationship of depression to medical illness. J Affective Disord1981; 3:111-21.
Glassman AHStetner F., Walsh BT et al. Heavy smokers, smoking cessation. and clonidine. JAMA1988,259:2863-66.
31.
Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LAPrevalence of smoking among psychiatric outpatients. Am J Psychiatry1986;143:993-97.
32.
Hall SM, McGee R., Tunstall JD, Benowitz N.Changes in food intake and activity after quitting smoking. J Consult Clin Psychol1989;57:81-86.
33.
Klesges RCIntroduction to the area review. Ann Behav Med1989;11(4):123-24.
34.
Gritz ER, Klesges RC, Meyers AW The smoking and body weight relationship: implications for intervention and postcessation weight control. Ann Behav Med1989; 11(4):144-53.
35.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol1983 ;51:390-95.
36.
Glasgow RE, Lichtenstein E.Long-term effects of behavioral smoking cessation interventions. Behav Ther1987; 18:297-324.
37.
Ardron M., Macfarlane IA, Robinson C., Van Heyningen C., Calverley Pma.Anti-smoking advice for young diabetic smokers: is it a waste of breath? Diabetic Med1988;5:667-70.
38.
Rigotti NA, Tesar GESmoking cessation in the prevention of cardiovascular disease. Cardiol Clin1985;3:245-57.
39.
Survey of attitudes toward smoking conducted by the Gallup Organization, Inc . New York: American Lung Association , July 1987.
40.
Fisher EB Jr. Prevention in adulthood: self-motivated quitting: maintenance of cessation. In: US Office on Smoking and Health. The health consequences of smoking: a report of the Surgeon General: CancerWashington, DC: Government Printing Office, 1982; DHHS publication no. (PHS)82-50179.
41.
Sees KL, Stalcup SACombining clonidine & nicotine replacement for treatment of nicotine withdrawal . J Psychoactive Drugs1989;21:355-59.
42.
Nett LMPharmacologic support for smokers. The Office Nurse1989 July-Aug: 31-36.
43.
Hughes J.Gust S., Keenan R., Fenwick J., Healey M.Nicotine vs. placebo gum in general medical practice. JAMA1989;261: 1300-05.
44.
Hall SM, Tunstall DG, Benowitz NL, Jones RTNicotine gum and behavioral treatment: a placebo controlled trial. J Consult Clin Psychol1987; 55:603-5.
45.
Sachs Dpl.Nicotine polacrilex: practical use requirements. In: Current pulmonology. Chicago: Year Book Medical Publishers, 1989.
46.
Carmody T., Loew D., Hall R., Breckenndge J., Hall S.Nicotine polacrilex: clinic-based strategies with chronically ill smokers . J Psychoactive Drugs1988;20:269-74.
47.
Fisher EB Jr, Rost K.Smoking cessation: a practical guide for the physician. Clin Chest Med1986;7:551-65.
48.
Glassman A. , Jackson W., Walsh BT, Roose S.Cigarette craving, smoking withdrawal, and clonidine. Science1984;226:864-66.
49.
Glassman AH , Stetner F., Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine. JAMA1988; 259:2863-66.
50.
Shiffman S.Relapse following smoking cessation: a situational anaylsis. J Consult Clin Psychol1982;50:71-86.
51.
Shiffman S., Read L., Maltese J., Rapkin D., Jarvik MEPreventing relapse in ex-smokers: a self-management approach. In: Marlatt GA, Gordon JR, eds. Relapse prevention. New York: Guilford, 1985.
52.
Marlatt GA, Gordon JR, eds. Relapse prevention: maintenance strategies in the treatment of addictive behamors. New York: Gudford Press, 1985.
53.
Kottke TE, Battista RN, DeFriese GHAttributes of successful smoking cessation interventions in medical practice: a meta-analysis of 39 controlled tnals. JAMA1988;259:2882-89.
54.
Ockene JKPhysician-delivered interventions for smoking cessation: strategies for increasing effectiveness. Prev Med1987; 16:723-37.
55.
Sachs Dpl.Office strategies to help your patients stop smoking. J Respir Dis1984;5(2):35-41.
56.
Nett LM, Dingus SMSmoking cessation techniques. In: Kacmarek R, Stoller JK, eds. Current respiratory care. Toronto: BC Decker, 1988.
57.
Fagerstrom KOMeasuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav1978; 3:235-41.
58.
National Heart, Lung, and Blood Institute.How you can help your patients to stop smoking: opportunity for respiratory care practitioners. Bethesda, Md: National Institutes of Health, 1989; DHHS publication no. (NIH)89-2961.
59.
Fisher EB Jr, Bishop DB, Goldmuntz MA, Jacobs A.Implications for the practicing physician of the psychosocial dimensions of smoking. Chest1988;93(2):69S-78S.
60.
Schneider N.How to use nicotine gum and other strategies to quit smoking. New York: Pocket Books, 1988.
